Cohen Milstein Seeks Lead In Zimmer Biomet PE Cashout Suit

By Rose Krebs (August 15, 2019, 4:34 PM EDT) -- Cohen Milstein Sellers & Toll PLLC told the Delaware Chancery Court it is best suited to serve as lead counsel of two derivative actions that claim Zimmer Biomet's stock prices plummeted after the medical device maker's officers hid compliance problems and helped private equity funds cash out to the tune of billions....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!